leading the field of in vivo immune cell reprogramming. We are pursuing products that modulate immune cells from within their native environment to enhance patient access and patient outcomes.
Employees: 11-50
Founded date: 2020
Investors 4
| Date | Name | Website |
| - | Tech Coast... | techcoasta... |
| - | SeedFolio | seedfolio.... |
| - | Biobrit | biobrit.co... |
| - | NuFund Ven... | nufund.com |